Dr. Shannon Buckley Appointed Co-Leader of HCI Cell Response and Regulation Program
Shannon Buckley, PhD, has been selected as Huntsman Cancer Institute (HCI) Comprehensive Cancer Center's Cell Response and Regulation Program co-leader. She will co-lead this program together with Dr. Sheri Holmen.
Dr. Buckley joined HCI in 2022 and holds the associate professor position in the Division of Hematology and Hematopoietic Malignancies at the University of Utah.
Her primary research objective is to employ genomic and proteomic approaches in leukemia and lymphoma to study molecular mechanisms regulating hematopoietic differentiation, survival, and malignant transformation. Dr. Buckley earned her molecular and cellular biology PhD from the University of Minnesota. Additionally, she completed a postdoctoral fellowship in stem cells and cancer biology at the New York University School of Medicine. The National Cancer Institute, the National Institute of Allergy and Infectious Disease, and the American Society of Hematology have supported Dr. Buckley's research program.
Dr. Buckley's expertise and contributions will undoubtedly enhance HCI's Comprehensive Cancer Center research endeavors. We eagerly anticipate Dr. Buckley's valuable insights and discoveries in cancer research.
